SAVINO ANGELA MARIA

Savino, A., Stuani, L. (2024). Targeting glycolysis to rescue 2-hydroxyglutarate immunosuppressive effects in dendritic cells and acute myeloid leukemia. HAEMATOLOGICA, 109(3) [10.3324/haematol.2023.284893]. Dettaglio

Oikonomou, A., Valsecchi, L., Quadri, M., Watrin, T., Scharov, K., Procopio, S., et al. (2023). High-throughput screening as a drug repurposing strategy for poor outcome subgroups of pediatric B-cell precursor Acute Lymphoblastic Leukemia. BIOCHEMICAL PHARMACOLOGY, 217(November 2023) [10.1016/j.bcp.2023.115809]. Dettaglio

Geron, I., Savino, A., Fishman, H., Tal, N., Brown, J., Turati, V., et al. (2022). An instructive role for Interleukin-7 receptor α in the development of human B-cell precursor leukemia. NATURE COMMUNICATIONS, 13 [10.1038/s41467-022-28218-7]. Dettaglio

Fazio, G., Bresolin, S., Silvestri, D., Quadri, M., Saitta, C., Vendramini, E., et al. (2022). PAX5 fusion genes are frequent in poor risk childhood acute lymphoblastic leukaemia and can be targeted with BIBF1120. EBIOMEDICINE, 83(September 2022) [10.1016/j.ebiom.2022.104224]. Dettaglio

Cheng, Y., Xie, W., Pickering, B., Chu, K., Savino, A., Yang, X., et al. (2021). N6-Methyladenosine on mRNA facilitates a phase-separated nuclear body that suppresses myeloid leukemic differentiation. CANCER CELL, 39(7), 958-972 [10.1016/j.ccell.2021.04.017]. Dettaglio